Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Ann Epidemiol. 2020 Oct 1;54:73–78. doi: 10.1016/j.annepidem.2020.09.013

Table 3.

Characteristics of Patients by Transgender/Gender Nonbinary Screening StatusScreened Positivea

Screened Positivea
Screened negative (n=17,850) n % p
Confirmed TGNBb (n=178) n % Not confirmed TGNB (n=35) n %
Age at entry to care, years (median, IQR)c 32.5 (25–39) 42.5 (34–49) 42 (34–49) <0.001
Male sex assigned at birth 177 (99.4) 21 (58.3) 10,626 (59.5) <0.001
Race/ethnicity 0.031
 Hispanic 66 (37.1) 21 (60.0) 6,247 (35.0)
 Black non-Hispanic 80 (44.9) 9 (25.7) 7,323 (41.0)
 Otherd 8 (4.5) 0 945 (5.3)
 Unknown 24 (13.5) 5 (14.3) 3,335 (18.7)
Insurance at first visit 0.006
 Public 142 (79.8) 26 (74.3) 12,229 (68.5)
 Commercial 9 (5.1) 4 (11.4) 1,905 (10.7)
 Self-pay 23 (12.9) 4 (11.4) 1,444 (8.1)
 Other/unknown 4 (1.8) 1 (2.9) 2,272 (12.7)
a

Excludes 23 patients who screened positive, but had no chart data for review

b

TGNB = transgender/gender nonbinary

c

IQR = Interquartile range

d

Includes: White, Asian, Native American, Native Alaskan, Asian/Pacific Islander